EC
XENE icon

EcoR1 Capital’s Xenon Pharmaceuticals XENE Stock Holding History

EcoR1 Capital’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-73,000
Closed -$842K – 28
2015
Q2 		$842K Sell
73,000
-147,570
-67% -$2.04M 0.28% 24
2015
Q1 		$3.72M Sell
220,570
-107,500
-33% -$1.99M 1.24% 20
2014
Q4 		$6.48M Buy
+328,070
New +$4.82M 3.28% 13

Other funds holding XENE

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

EcoR1 Capital's XENE Position: Q3 2015 in Review

EcoR1 Capital sold out of Xenon Pharmaceuticals (XENE) in Q3 2015, closing a stake of 73,000 shares — an estimated $842K sold.

EcoR1 Capital first reported a position in XENE in Q4 2014 and held it in 3 quarters. The position peaked at $6.48M in Q4 2014. 25 funds tracked by Wall St. Rank hold XENE as of Q3 2015.

  • EcoR1 Capital reported no remaining Xenon Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • EcoR1 Capital sold 73,000 Xenon Pharmaceuticals shares in Q3 2015, an estimated $842K.
  • EcoR1 Capital first reported a position in Xenon Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • EcoR1 Capital's Xenon Pharmaceuticals position peaked at $6.48M in Q4 2014.
  • 25 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2015.

Based on EcoR1 Capital's 13F filing for Q3 2015, filed 16 Nov 2015.